Cargando…
Structure-based engineering of a novel CD3ε-targeting antibody for reduced polyreactivity
Bispecific antibodies continue to represent a growth area for antibody therapeutics, with roughly a third of molecules in clinical development being T-cell engagers that use an anti-CD3 binding arm. CD3 antibodies possessing cross-reactivity with cynomolgus monkey typically recognize a highly electr...
Autores principales: | Liu, Catherine Y, Ahonen, Cory L, Brown, Michael E, Zhou, Ling, Welin, Martin, Krauland, Eric M, Pejchal, Robert, Widboom, Paul F, Battles, Michael B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10072072/ https://www.ncbi.nlm.nih.gov/pubmed/36991534 http://dx.doi.org/10.1080/19420862.2023.2189974 |
Ejemplares similares
-
An in silico method to assess antibody fragment polyreactivity
por: Harvey, Edward P., et al.
Publicado: (2022) -
Aromatic Guanylhydrazones for the Control of Heme-Induced
Antibody Polyreactivity
por: Božinović, Nina, et al.
Publicado: (2019) -
Conformational Plasticity in Broadly Neutralizing HIV-1 Antibodies Triggers Polyreactivity
por: Prigent, Julie, et al.
Publicado: (2018) -
Therapeutic Potential of HLA-I Polyreactive mAbs Mimicking the HLA-I Polyreactivity and Immunoregulatory Functions of IVIg
por: Ravindranath, Mepur H., et al.
Publicado: (2021) -
Stimulation of Toll-Like Receptors profoundly influences the titer of polyreactive antibodies in the circulation
por: Gunti, Sreenivasulu, et al.
Publicado: (2015)